Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

<p>Abstract</p> <p>Background</p> <p>The relevance of angiogenesis inhibition in the treatment of glioblastoma multiforme (GBM) should be considered in the unique context of malignant brain tumours. Although patients benefit greatly from reduced cerebral oedema and intr...

Full description

Bibliographic Details
Main Authors: Richel Dirk J, van Linde Myra E, Stalpers Lukas JA, Claes An, van Tellingen Olaf, Verhoeff Joost JC, Leenders William PJ, van Furth Wouter R
Format: Article
Language:English
Published: BMC 2009-12-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/444

Internet

http://www.biomedcentral.com/1471-2407/9/444

Similar Items